BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23881300)

  • 41. [Preliminary study of combining T2-weighted imaging, diffusion weighted imaging and dynamic contrast enhanced-magnetic resonance imaging for diagnosing prostatic central gland cancer].
    Li P; Yang W; Chen Z; Guo Y; Cai L; Du Y; Li Y
    Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(31):2448-51. PubMed ID: 25400054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
    Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
    Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Computed diffusion-weighted MR imaging for visualization of pancreatic adenocarcinoma: Comparison with acquired diffusion-weighted imaging.
    Fukukura Y; Kumagae Y; Hakamada H; Shindo T; Takumi K; Kamimura K; Nakajo M; Umanodan A; Yoshiura T
    Eur J Radiol; 2017 Oct; 95():39-45. PubMed ID: 28987696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and validation of a logistic regression model to distinguish transition zone cancers from benign prostatic hyperplasia on multi-parametric prostate MRI.
    Iyama Y; Nakaura T; Katahira K; Iyama A; Nagayama Y; Oda S; Utsunomiya D; Yamashita Y
    Eur Radiol; 2017 Sep; 27(9):3600-3608. PubMed ID: 28289941
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The clinical value of 3 tesla diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer].
    Shimamoto T; Ashida S; Yamasaki I; Kuno T; Fukuhara H; Fukata S; Satake H; Tamura K; Karashima T; Kamata M; Inoue K; Shuin T; Kariya S; Ogawa Y
    Hinyokika Kiyo; 2012 Mar; 58(3):143-8. PubMed ID: 22495042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of computed high b-value images on the diagnostic accuracy of DWI for prostate cancer: A receiver operating characteristics analysis.
    Ning P; Shi D; Sonn GA; Vasanawala SS; Loening AM; Ghanouni P; Obara P; Shin LK; Fan RE; Hargreaves BA; Daniel BL
    Sci Rep; 2018 Feb; 8(1):3409. PubMed ID: 29467370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
    Tanimoto A; Nakashima J; Kohno H; Shinmoto H; Kuribayashi S
    J Magn Reson Imaging; 2007 Jan; 25(1):146-52. PubMed ID: 17139633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diffusion-weighted MRI for differentiation of benign from malignant lesions in the gallbladder.
    Lee NK; Kim S; Kim TU; Kim DU; Seo HI; Jeon TY
    Clin Radiol; 2014 Feb; 69(2):e78-85. PubMed ID: 24290779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.
    Yuan Q; Costa DN; Sénégas J; Xi Y; Wiethoff AJ; Rofsky NM; Roehrborn C; Lenkinski RE; Pedrosa I
    J Magn Reson Imaging; 2017 Mar; 45(3):908-916. PubMed ID: 27442039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diffusion-weighted imaging in the assessment of prostate cancer: Comparison of zoomed imaging and conventional technique.
    Brendle C; Martirosian P; Schwenzer NF; Kaufmann S; Kruck S; Kramer U; Notohamiprodjo M; Nikolaou K; Schraml C
    Eur J Radiol; 2016 May; 85(5):893-900. PubMed ID: 27130048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diffusion-weighted imaging for prostate cancer localization: comparison of apparent diffusion coefficient values in cancerous and non-cancerous tissues, and the Gleason score of the radical prostatectomy specimens].
    Kobayashi H; Kitamura K; Mizukami S; Hanazawa K; Sakamoto Y
    Nihon Hinyokika Gakkai Zasshi; 2013 May; 104(3):489-95. PubMed ID: 23819360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The applied research of simultaneous image acquisition of T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) in the assessment of patients with prostate cancer.
    Liu Y; Wang W; Qin XB; Wang HH; Gao G; Zhang XD; Wang XY
    Asian J Androl; 2019; 21(2):177-182. PubMed ID: 30381579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Voxel-based supervised machine learning of peripheral zone prostate cancer using noncontrast multiparametric MRI.
    Gholizadeh N; Simpson J; Ramadan S; Denham J; Lau P; Siddique S; Dowling J; Welsh J; Chalup S; Greer PB
    J Appl Clin Med Phys; 2020 Oct; 21(10):179-191. PubMed ID: 32770600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI.
    Wu LM; Chen XX; Xu JR; Zhang XF; Suo ST; Yao QY; Fan Y; Hu J
    Acad Radiol; 2013 Aug; 20(8):939-46. PubMed ID: 23746384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the Prostate Imaging Reporting and Data System for Magnetic Resonance Imaging Diagnosis of Prostate Cancer in Patients with Prostate-specific Antigen <20 ng/ml.
    Wang X; Wang JY; Li CM; Zhang YQ; Wang JL; Wan B; Zhang W; Chen M; Li SY; Wan G; Liu M
    Chin Med J (Engl); 2016 Jun; 129(12):1432-8. PubMed ID: 27270538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Image Quality Assessment of 2D
    Hausmann D; Liu J; Budjan J; Reichert M; Ong M; Meyer M; Smakic A; Grimm R; Strecker R; Schoenberg SO; Wang X; Attenberger UI
    Anticancer Res; 2018 Feb; 38(2):969-978. PubMed ID: 29374729
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MRI for prostate cancer: can computed high b-value DWI replace native acquisitions?
    Jendoubi S; Wagner M; Montagne S; Ezziane M; Mespoulet J; Comperat E; Estellat C; Baptiste A; Renard-Penna R
    Eur Radiol; 2019 Oct; 29(10):5197-5204. PubMed ID: 30887197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of Local Recurrence of Prostate Cancer After Radical Prostatectomy Using Endorectal Coil MRI at 3 T: Addition of DWI and Dynamic Contrast Enhancement to T2-Weighted MRI.
    Kitajima K; Hartman RP; Froemming AT; Hagen CE; Takahashi N; Kawashima A
    AJR Am J Roentgenol; 2015 Oct; 205(4):807-16. PubMed ID: 26397329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.